BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28230926)

  • 21. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
    Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.
    Sung JY; Ahn HK; Kwon JE; Jeong H; Baek CH; Son YI; Ahn YC; Park K; Ahn MJ; Ko YH
    J Oral Pathol Med; 2012 May; 41(5):415-23. PubMed ID: 22077630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of TMPRSS4 in patients with salivary adenoid cystic carcinoma: correlation with clinicopathological features and prognosis.
    Dai W; Zhou Q; Xu Z; Zhang E
    Med Oncol; 2013 Dec; 30(4):749. PubMed ID: 24132607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
    Humtsoe JO; Kim HS; Leonard B; Ling S; Keam B; Marchionni L; Afsari B; Considine M; Favorov AV; Fertig EJ; Kang H; Ha PK
    Cancer Res; 2021 Feb; 81(4):1001-1013. PubMed ID: 33408119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal activation of the Akt signaling pathway in adenoid cystic carcinoma.
    Branco KFCC; Ribeiro ALR; de Mendonça RP; de Jesus Viana Pinheiro J; da Silva Kataoka MS; Arnaud MVC; de Melo Alves Junior S
    Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):3039-3047. PubMed ID: 30367261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy.
    Liu H; Du L; Wang R; Wei C; Liu B; Zhu L; Liu P; Liu Q; Li J; Lu SL; Xiao J
    Oncotarget; 2015 May; 6(13):11477-91. PubMed ID: 25909167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.
    Vékony H; Raaphorst FM; Otte AP; van Lohuizen M; Leemans CR; van der Waal I; Bloemena E
    J Clin Pathol; 2008 Jun; 61(6):744-9. PubMed ID: 18326020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AKT3 drives adenoid cystic carcinoma development in salivary glands.
    Zboray K; Mohrherr J; Stiedl P; Pranz K; Wandruszka L; Grabner B; Eferl R; Moriggl R; Stoiber D; Sakamoto K; Wagner KU; Popper H; Casanova E; Moll HP
    Cancer Med; 2018 Feb; 7(2):445-453. PubMed ID: 29282901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
    Xie S; Yu X; Li Y; Ma H; Fan S; Chen W; Pan G; Wang W; Zhang H; Li J; Lin Z
    Mol Ther; 2018 Dec; 26(12):2766-2778. PubMed ID: 30217729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
    Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
    J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.
    Suzuki S; Dobashi Y; Minato H; Tajiri R; Yoshizaki T; Ooi A
    Virchows Arch; 2012 Sep; 461(3):271-82. PubMed ID: 22828828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical regions and spreading of runt-related transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma.
    Ge MH; Chen C; Xu JJ; Ling ZQ
    Hum Pathol; 2011 Dec; 42(12):1862-72. PubMed ID: 21658745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
    Holst VA; Marshall CE; Moskaluk CA; Frierson HF
    Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Autophagy and Reactive Oxygen Species-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma.
    Koo JS; Kim JW; Yoon JS
    Yonsei Med J; 2016 Mar; 57(2):482-9. PubMed ID: 26847304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
    Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
    Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
    Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinoma.
    Dai W; Tan X; Sun C; Zhou Q
    Int J Mol Sci; 2014 May; 15(5):8393-406. PubMed ID: 24828201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C.
    Tang YL; Liu X; Gao SY; Feng H; Jiang YP; Wang SS; Yang J; Jiang J; Ma XR; Tang YJ; Chen Y; Liang XH
    Oncotarget; 2015 Apr; 6(11):9031-44. PubMed ID: 25797250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
    Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF
    Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
    Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
    Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.